Cargando…
Complications Following BellaGen™ Injection
BellaGen™ is an injectable acellular dermal matrix granule derived from donated human skin tissue that was recently developed for soft tissue augmentation. Its use has been sporadically reported in penile girth enhancement procedures. Many cases of complications have been reported after injecting ac...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Dermatological Association; The Korean Society for Investigative Dermatology
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276783/ https://www.ncbi.nlm.nih.gov/pubmed/22346264 http://dx.doi.org/10.5021/ad.2011.23.S3.S306 |
_version_ | 1782223403505156096 |
---|---|
author | Park, Mi Kyung Kim, Hyun Kyu Park, Kui Young Li, Kapsok Seo, Seong Jun Hong, Chang Kwun |
author_facet | Park, Mi Kyung Kim, Hyun Kyu Park, Kui Young Li, Kapsok Seo, Seong Jun Hong, Chang Kwun |
author_sort | Park, Mi Kyung |
collection | PubMed |
description | BellaGen™ is an injectable acellular dermal matrix granule derived from donated human skin tissue that was recently developed for soft tissue augmentation. Its use has been sporadically reported in penile girth enhancement procedures. Many cases of complications have been reported after injecting acellular dermal matrices like AlloDerm or SureDerm™ but few reports on complications associated with BellaGen™ injection. We report here on penile skin inflammation and necrosis following augmentation phalloplasty with BellaGen™, which developed 3 days after the injection and persisted for more than 2 weeks. The patient had a 15 year history of type 2 diabetes mellitus, and he was treated with oral antibiotics and wet dressings with KMNO4 solution to combine preservation of the remaining penile soft tissue with debridement of avascular tissue. The lesion improved with this treatment, but the patient experienced pain for about 2 weeks. All patients should be informed of the potential complications with the use of injectable acellular dermal matrices before treatment. Patient selection for augmentation is also important to have the most desirable results. |
format | Online Article Text |
id | pubmed-3276783 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Korean Dermatological Association; The Korean Society for Investigative Dermatology |
record_format | MEDLINE/PubMed |
spelling | pubmed-32767832012-02-16 Complications Following BellaGen™ Injection Park, Mi Kyung Kim, Hyun Kyu Park, Kui Young Li, Kapsok Seo, Seong Jun Hong, Chang Kwun Ann Dermatol Case Report BellaGen™ is an injectable acellular dermal matrix granule derived from donated human skin tissue that was recently developed for soft tissue augmentation. Its use has been sporadically reported in penile girth enhancement procedures. Many cases of complications have been reported after injecting acellular dermal matrices like AlloDerm or SureDerm™ but few reports on complications associated with BellaGen™ injection. We report here on penile skin inflammation and necrosis following augmentation phalloplasty with BellaGen™, which developed 3 days after the injection and persisted for more than 2 weeks. The patient had a 15 year history of type 2 diabetes mellitus, and he was treated with oral antibiotics and wet dressings with KMNO4 solution to combine preservation of the remaining penile soft tissue with debridement of avascular tissue. The lesion improved with this treatment, but the patient experienced pain for about 2 weeks. All patients should be informed of the potential complications with the use of injectable acellular dermal matrices before treatment. Patient selection for augmentation is also important to have the most desirable results. Korean Dermatological Association; The Korean Society for Investigative Dermatology 2011-12 2011-12-27 /pmc/articles/PMC3276783/ /pubmed/22346264 http://dx.doi.org/10.5021/ad.2011.23.S3.S306 Text en Copyright © 2011 Korean Dermatological Association; The Korean Society for Investigative Dermatology http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Park, Mi Kyung Kim, Hyun Kyu Park, Kui Young Li, Kapsok Seo, Seong Jun Hong, Chang Kwun Complications Following BellaGen™ Injection |
title | Complications Following BellaGen™ Injection |
title_full | Complications Following BellaGen™ Injection |
title_fullStr | Complications Following BellaGen™ Injection |
title_full_unstemmed | Complications Following BellaGen™ Injection |
title_short | Complications Following BellaGen™ Injection |
title_sort | complications following bellagen™ injection |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276783/ https://www.ncbi.nlm.nih.gov/pubmed/22346264 http://dx.doi.org/10.5021/ad.2011.23.S3.S306 |
work_keys_str_mv | AT parkmikyung complicationsfollowingbellageninjection AT kimhyunkyu complicationsfollowingbellageninjection AT parkkuiyoung complicationsfollowingbellageninjection AT likapsok complicationsfollowingbellageninjection AT seoseongjun complicationsfollowingbellageninjection AT hongchangkwun complicationsfollowingbellageninjection |